SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042876
Filing Date
2021-08-10
Accepted
2021-08-10 07:08:43
Documents
73
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fulc-10q_20210630.htm   iXBRL 10-Q 3204681
2 EX-10.1 fulc-ex101_12.htm EX-10.1 74180
3 EX-31.1 fulc-ex311_11.htm EX-31.1 11867
4 EX-31.2 fulc-ex312_9.htm EX-31.2 12705
5 EX-32.1 fulc-ex321_10.htm EX-32.1 6261
6 EX-32.2 fulc-ex322_7.htm EX-32.2 6211
7 GRAPHIC gm12ttedtb1e000001.jpg GRAPHIC 29619
8 GRAPHIC gm12ttedtb1e000002.jpg GRAPHIC 30264
  Complete submission text file 0001564590-21-042876.txt   9421095

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA fulc-20210630.xsd EX-101.SCH 53249
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fulc-20210630_cal.xml EX-101.CAL 50203
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fulc-20210630_def.xml EX-101.DEF 196942
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE fulc-20210630_lab.xml EX-101.LAB 394655
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fulc-20210630_pre.xml EX-101.PRE 319336
14 EXTRACTED XBRL INSTANCE DOCUMENT fulc-10q_20210630_htm.xml XML 1625705
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38978 | Film No.: 211158402
SIC: 2834 Pharmaceutical Preparations